Literature DB >> 11713106

Rho-kinase activation is involved in hypoxia-induced pulmonary vasoconstriction.

Z Wang1, N Jin, S Ganguli, D R Swartz, L Li, R A Rhoades.   

Abstract

Rho-associated serine/threonine kinase (Rho-kinase) is a downstream effector of small GTPase RhoA that has recently been shown to play an important role in regulating smooth muscle contraction. The present study investigated the role of Rho/ Rho-kinase in hypoxia-induced pulmonary vasoconstriction (HPV). Small pulmonary resistance vessels and cultured pulmonary arterial smooth muscle cells (PASMCs) from the rat were used. PASMCs exposed to hypoxia (PO(2) = 26 +/- 2 mm Hg) showed a significant increase in Rho-kinase activity. Exposure to hypoxia for 20, 40, 60, 90, and 120 min also resulted in a significant increase in myosin light chain (MLC) phosphorylation at all time points in PASMCs. Hypoxia-induced MLC phosphorylation was inhibited by Y-27632 (a Rho-kinase inhibitor), exoenzyme C3 (a specific Rho inhibitor), or toxin B (an inhibitor for Rho proteins). In addition, hypoxia-induced Rho-kinase activation was blocked by C3 and toxin B. Small rat intrapulmonary arterial rings, which were made hypoxic (PO(2) = 30 +/- 3 mm Hg), showed a slow sustained contraction, and Y-27632 caused a significant relaxation during the sustained phase of HPV in a concentration-dependent manner. In summary, the data show that Rho-kinase is activated by hypoxia in PASMCs, and Rho/Rho-kinase is functionally linked to hypoxia-induced MLC phosphorylation and plays a role in the sustained phase of HPV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11713106     DOI: 10.1165/ajrcmb.25.5.4461

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  42 in total

1.  TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation.

Authors:  C Seyler; E Duthil-Straub; E Zitron; J Gierten; E P Scholz; R H A Fink; C A Karle; R Becker; H A Katus; D Thomas
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Acute oxygen-sensing mechanisms.

Authors:  E Kenneth Weir; José López-Barneo; Keith J Buckler; Stephen L Archer
Journal:  N Engl J Med       Date:  2005-11-10       Impact factor: 91.245

3.  Ca2+-desensitizing hypoxic vasorelaxation: pivotal role for the myosin binding subunit of myosin phosphatase (MYPT1) in porcine coronary artery.

Authors:  Robert L Wardle; Min Gu; Yukisato Ishida; Richard J Paul
Journal:  J Physiol       Date:  2006-01-26       Impact factor: 5.182

Review 4.  Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension.

Authors:  M Oka; K A Fagan; P L Jones; I F McMurtry
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

5.  Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension.

Authors:  Christophe Guilluy; Vincent Sauzeau; Malvyne Rolli-Derkinderen; Patrice Guérin; Christine Sagan; Pierre Pacaud; Gervaise Loirand
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

6.  Enhancement of myofilament calcium sensitivity by acute hypoxia in rat distal pulmonary arteries.

Authors:  Letitia Weigand; Larissa A Shimoda; J T Sylvester
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-06-10       Impact factor: 5.464

7.  Proteomic profile of an acute partial bladder outlet obstruction.

Authors:  Bader Alsaikhan; Richard Fahlman; Jie Ding; Edward Tredget; Peter D Metcalfe
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

8.  Hypoxia reduces TGFbeta1-induced corneal keratocyte myofibroblast transformation.

Authors:  Dongmei Xing; Joseph A Bonanno
Journal:  Mol Vis       Date:  2009-09-11       Impact factor: 2.367

9.  Effect of chronic perinatal hypoxia on the role of rho-kinase in pulmonary artery contraction in newborn lambs.

Authors:  Arlin B Blood; Michael H Terry; Travis A Merritt; Demosthenes G Papamatheakis; Quintin Blood; Jonathon M Ross; Gordon G Power; Lawrence D Longo; Sean M Wilson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-11-14       Impact factor: 3.619

Review 10.  RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension.

Authors:  Scott A Barman; Shu Zhu; Richard E White
Journal:  Vasc Health Risk Manag       Date:  2009-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.